Navigation Links
Presentation Schedules, Stock Movements, Agreements, and New Appointments - Research Report on Celgene, Merck, Bristol-Myers, Valeant, and Mylan
Date:1/7/2014

p>
  1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
  2. Information in this release is fact checked and produced on a best efforts basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
  3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

  1. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco@EquityNewsNetwork.com.
  2. For any urgent concerns or inquiries, please contact us at compliance@EquityNewsNetwork.com.
  3. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research@EquityNewsNetwork.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider represented by Nidhi Vatsal, CFA, has only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the inf
'/>"/>

SOURCE Analysts' Corner
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Cepheid to Webcast Upcoming Financial Presentation
2. Quarterly Dividends, Clinical Trial Results, Dental Exhibition Updates, and Upcoming Presentation Schedules - Research Report Quest Diagnostics, Avanir, Sirona, Ligand and Genomic Health
3. Pharmacyclics Announces Data Presentations for Ibrutinib in B-Cell Malignancies
4. Cell Therapeutics Announces Presentation of Interim Results from Phase 2 Tosedostat Trial in Older Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) at ASH Annual Meeting
5. Ambit Announces Presentations At The 55th Annual Meeting Of The American Society Of Hematology (ASH)
6. Highland Instruments, Inc., Announces Presentation of "Effects of Electrosonic Stimulation on the Perception of Chronic Pain Due to Osteoarthritis of the Knee."
7. Nora Therapeutics Announces New Time for Presentation at the Oppenheimer 24th Annual Healthcare Conference
8. Boston Therapeutics, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
9. HeartWare Presentation At The Oppenheimer 24th Annual Healthcare Conference To Be Webcast
10. Regeneron Announces Upcoming 2013 Investor Conference Presentation
11. Updated Presentation Time: Mirati Therapeutics to Present at the 25th Annual Piper Jaffray Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... , Aug. 27, 2014 About 8 ... legs due to buildup of fatty plaque in the ... the aging patient population and in incidences of diabetes ... offers its Lower Extremity Arterial RevascularizatioN (LEARN) ... Endovascular specialists and interested residents and fellows will ...
(Date:8/27/2014)... , Aug. 27, 2014 Reportlinker.com ... available in its catalogue: Global Orthopedic ... http://www.reportlinker.com/p02316671/Global-Orthopedic-Soft-Tissue-Repair-Devices-Market-2014-2018.html About ... are the mass of cells that connect, support, ... orthopedic soft tissues such as tendons, ligaments, cartilage, ...
(Date:8/27/2014)... BURLINGTON, Mass. , Aug. 27, 2014 /PRNewswire/ ... six different specialties (medical oncology, hematology-oncology, rheumatology, gastroenterology, ... of clinical trials that a biosimilar has been ... which biosimilar product they choose to prescribe. ... Advisory Service report entitled Acceptance of ...
Breaking Medicine Technology:LEARN to Treat Peripheral Arterial Disease Patients 2LEARN to Treat Peripheral Arterial Disease Patients 3Global Orthopedic Soft Tissue Repair Devices Market 2014-2018 2Global Orthopedic Soft Tissue Repair Devices Market 2014-2018 3Global Orthopedic Soft Tissue Repair Devices Market 2014-2018 4Global Orthopedic Soft Tissue Repair Devices Market 2014-2018 5Surveyed Physicians Expect to Choose Between Future Biosimilars Based on Robustness and Number of Clinical Trials 2
... SOUTH EASTON, Mass., July 1 Pressure,BioSciences, Inc. ... scientists,from the New York University ("NYU") School of ... on advances they made in the,areas of breast ... The results were generated in studies using PBI,s ...
... Agennix Incorporated today announced,the publication of final results ... in patients who had failed previous treatment for,advanced ... the study,which were reported in the July 1 ... demonstrate that talactoferrin is active in RCC, has ...
Cached Medicine Technology:Pressure Cycling Technology (PCT) Results in a Higher Yield of Proteins and in the Extraction of Proteins Not Previously Identified in Cancer, Stroke, and IVF Studies 2Pressure Cycling Technology (PCT) Results in a Higher Yield of Proteins and in the Extraction of Proteins Not Previously Identified in Cancer, Stroke, and IVF Studies 3Results Published in the Journal 'Cancer' Demonstrate that Oral Talactoferrin Alfa is Active as Monotherapy in Previously Treated Patients with Metastatic Renal Cell Carcinoma 2Results Published in the Journal 'Cancer' Demonstrate that Oral Talactoferrin Alfa is Active as Monotherapy in Previously Treated Patients with Metastatic Renal Cell Carcinoma 3Results Published in the Journal 'Cancer' Demonstrate that Oral Talactoferrin Alfa is Active as Monotherapy in Previously Treated Patients with Metastatic Renal Cell Carcinoma 4Results Published in the Journal 'Cancer' Demonstrate that Oral Talactoferrin Alfa is Active as Monotherapy in Previously Treated Patients with Metastatic Renal Cell Carcinoma 5
(Date:8/27/2014)... WA (PRWEB) August 27, 2014 Sound ... call center solutions, and cloud-based business communication systems, has ... to Know about HIPAA-compliant Secure Text Messaging .” The ... healthcare professionals need to do to remain compliant with ... author of the article and C.O.O. at Sound Telecom, ...
(Date:8/27/2014)... August 27, 2014 Parker Waichman LLP, ... rights of victims injured by defective medical devices, reports ... for discovery procedures, specifically Collection and Preservation of Evidence, ... transvaginal mesh devices. (MDL No. 2187, In Re: C.R. ... United States District Court, Southern District or West Virginia; ...
(Date:8/27/2014)... half a glass of wine at a time may keep you ... asked 74 college students and staff to pour red and white ... of wine in them. The participants were told to pour an ... thumb" about how much to pour -- such as limiting it ... poured less wine than those without set guidelines. "About 70 ...
(Date:8/27/2014)... 2014 Power morcellator lawsuits ( http://www.gynecaremorcellatorlawsuit.com/ ... behalf of women who allegedly experienced the spread of ... reports. According to court documents, one of the most ... U.S. District Court, Northern District of New York, on ... of a power morcellator manufactured Karl Storz Endoscopy - ...
(Date:8/27/2014)... 27, 2014 When Jagger was 20 years ... his mother; one that he credits as one of the ... had news that she could set him up with a ... disabilities. Jagger took that job, and he has now spent ... past two decades, he also worked in school boards, employment ...
Breaking Medicine News(10 mins):Health News:Sound Telecom Releases Article on Secure Messaging with Huge Implications for the Healthcare Industry 2Health News:Sound Telecom Releases Article on Secure Messaging with Huge Implications for the Healthcare Industry 3Health News:New Discovery Rules Have Been Put in Place by the Court Overseeing C.R. Bard Transvaginal Mesh Litigation, Parker Waichman LLP Comments 2Health News:New Discovery Rules Have Been Put in Place by the Court Overseeing C.R. Bard Transvaginal Mesh Litigation, Parker Waichman LLP Comments 3Health News:New Discovery Rules Have Been Put in Place by the Court Overseeing C.R. Bard Transvaginal Mesh Litigation, Parker Waichman LLP Comments 4Health News:'Half a Glass' Rule May Curb Overdrinking 2Health News:Power Morcellator Lawsuit Alleges Storz Morcellator Caused Spread of Aggressive Uterine Cancer, Bernstein Liebhard LLP Reports 2Health News:Power Morcellator Lawsuit Alleges Storz Morcellator Caused Spread of Aggressive Uterine Cancer, Bernstein Liebhard LLP Reports 3Health News:Power Morcellator Lawsuit Alleges Storz Morcellator Caused Spread of Aggressive Uterine Cancer, Bernstein Liebhard LLP Reports 4Health News:Fitness on the Go Expands into Liberty Village, City Place and Harbourfront Communities 2Health News:Fitness on the Go Expands into Liberty Village, City Place and Harbourfront Communities 3Health News:Fitness on the Go Expands into Liberty Village, City Place and Harbourfront Communities 4
... Oct. 27, 2011 Are children suffering needlessly after ... believe so. An operation can be one of ... a UCI study, many of them experience unnecessary postsurgical ... is well understood and treated in adults but has ...
... FINDINGS: Whitehead Institute scientists have determined that master transcription ... In this way, signaling pathways are targeted to genes ... tailor gene expression to control cell state, growth, differentiation, ... pathways operate properly, a cell receives instructions from its ...
... -- One of the things that makes inhalational anthrax so ... number of inhaled anthrax spores can turn into a lethal ... she has something worse than the flu and seeks treatment, ... be no help against the spreading bacteria and the potent ...
... and financially during adolescence and early adulthood takes its toll ... in middle aged men and women, irrespective of how tough ... E. Gustafsson from Ume University in Sweden and colleagues, experience ... into adulthood is linked to a rise in disease risk ...
... presence of a predator causes enough stress to kill a ... prey to eat it, say biologists at the University of ... eaten is an important topic in ecology, and we,ve learned ... prey interactions," says Professor Locke Rowe, chair of the Department ...
... The New England Regional Spinal Cord Injury Center at ... Spinal Cord Injury Model System (SCIMS) by the National ... are awarded in five-year cycles by the NIDRR through ... NIDRR supports innovative research in the delivery, demonstration ...
Cached Medicine News:Health News:How major signaling pathways are wired to our genome gives new insight into disease processes 2Health News:How major signaling pathways are wired to our genome gives new insight into disease processes 3Health News:Natural killer cells could be key to anthrax defense 2Health News:Hard times during adolescence point to health problems later in life 2Health News:Insects are scared to death of fish 2
... hood mounts on a standard ring stand ... x 1/2" ) mounting rod. The 14cm ... above the source of fumes. A top ... connects to an aspirator or vacuum source. ...
... cost effective alternative to metal fume hoods. ... resistant, and corrosion proof yet allows light ... For added convenience and accessibility, the door ... visibility and may be set open at ...
These handy dispensers save space and organize gloves in labs and next to hand washers. Static-dissipative PVC eliminates static charges and the particles they attract . Many other sizes and custom c...
... the most convenient for sectioning of specimens ... laboratories. Specimen rise is automatic and accurate ... 12 microns in increments of 0.5 microns. ... Associated Products, Vibratomes Freezing Stages ...
Medicine Products: